These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, report not yet due 2016-001033-27 REMODEL - WM3 An Open Label non-randomized Phase II Study exploring «chemo-free » treatment association with Idelalisib + Obinutuzumab in Patient with relapsed/refractory Waldenstrom’s Macroglobulinem... 2023-04-13 not-yet-due
Ongoing 2018-001475-20 Preemptive therapy with Venetoclax for high risk CLL stage A patients, a phase II trial of the FILO PREVENE (PREemptive Venetoclax) trial not-yet-due
Completed, but no date 2018-003483-32 BLINAtumomab after R-CHOP debulking therapy for patients with Richter Transformation. bad-data
Ongoing 2020-006081-36 STop and restart Acalabrutinib In fRail patients with previously untreated CLL (STAIR) Arrêt et reprise de l’Acalabrutinib chez les patients fragiles présentant une leucémie lymphoîde chronique no... not-yet-due
Completed, but no date 2021-002042-32 A phase II study of CPX-351 monotherapy in Acute Myeloid Leukemia secondary to Myeloproliferative neoplams Étude de phase ii d’une monothérapie par cpx-351 dans les leucémies aiguës secondaires à ... bad-data